News and Trends 9 Jun 2023
Chronic myeloid leukemia: Novartis survey signals need for better patient-physician communication
Only 19% to 26% of patients with chronic myeloid leukemia (CML) discuss treatment decisions with their physician, a survey by Swiss-based pharmaceutical Novartis has revealed. The Survey of Unmet Needs…